Please turn JavaScript on
READ
PUBLISH
My newsFind FeedsDelivery settingsPlansMy earnings
HelpBlog
Login
Find more feeds

Health Law Advisor - Laws and Regulations Affecting Health Care and Life Sciences - Featuring HEAL® | Epstein Becker Green

Want to stay in touch with the latest updates from Health Law Advisor - Laws and Regulations Affecting Health Care and Life Sciences - Featuring HEAL® | Epstein Becker Green? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Health Law Advisor - Laws and Regulations Affecting Health Care and Life Sciences - Featuring HEAL® | Epstein Becker Green

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.46 / week

Message History

OIG Limits Sign-On Bonuses to In-Home Family Caregivers

On January 5, 2026, the Office of Inspector General (“OIG”) for the Department of Health and Human Services published Advisory Opinion No. 25-12 (“AO 25-12”), an unfavorable opinion regarding sign-on bonuses offered to caregivers who provide in-home sup...


Read full story
Governing Health AI Development and Adoption: Insights from HHS’s Recently Announced Strategy to Promote AI in Healt...

The Trump Administration continues to pursue a policy of AI dominance, which began with its January 23, 2025 executive order to remove “barriers” to Artificial Intelligence (“AI”) innovati...


Read full story
Stranger Things: New FDA Updates Flip Expectations for the Med Tech Industry in 2026 Upside Down

Tuesday, January 6, 2026, yielded two surprising updates from the Food and Drug Administration (“FDA”) Center for Devices and Radiological Health. While many experts have been forecasting continued tension between med tech innovators and the agency based on enforcement trends in 2025, FDA released two policy updates that, in fact, purport to ease the burdens on developers of ...


Read full story
The DOJ’s Bulk Sensitive Data Rule and Your Obligation to "Know Your Vendor”

This blog post is the latest installment in a series focused on the DOJ’s Bulk Sensitive Data Rule, and is intended to help stakeholders navigate the complex rule’s requirements and move toward full compliance.

Epstein Becker Green’s


Read full story
Courts and CMS So Far Agree: States are Preempted from Acting on MA Plan Marketing

Several actions have occurred since Epstein Becker & Green, P.C.’s blog post, dated November 19, 2025, regarding state insurance departments scrutinizing Medicare Advantage and MedSupp Trade Pract...


Read full story